In the serum, IGFBP-1 and -2 were increased in all NAFLD stages, but no differences were observed among them (Figure 3b,d); IGFBP-7 was increased during both borderline and definite NASH compared with the controls (Figure 3f). The gene discussed is IGFBP1; the disease is metabolic dysfunction-associated steatotic liver disease.